AKBA: Akebia Therapeutics Inc

3.51 USD 0.12 (3.31%)

Sektor: Gesundheitswesen Basis: US Dollar Gewinnwährung: US Dollar

Der Wechselkurs von AKBA hat sich für heute um -3.31% verändert. Im Laufe des Tages wurde das Instrument von einem Tief von 3.47 bis zu einem Hoch von 3.64 gehandelt.

Verfolgen Sie die Akebia Therapeutics Inc-Dynamik. Mit Echtzeit-Kursen können Sie schnell auf Marktveränderungen reagieren. Indem Sie zwischen verschiedenen Zeitrahmen wechseln, können Sie Kurstrends und -dynamik nach Minuten, Stunden, Tagen, Wochen und Monaten verfolgen. Nutzen Sie diese Informationen, um Marktveränderungen vorherzusagen und fundierte Handelsentscheidungen zu treffen.

Vollbild-Chart

AKBA News

Zacks 16:00 Akebia Therapeutics (AKBA) Upgraded to Strong Buy: Here's What You Should Know
Zacks 13:40 Is Akebia Therapeutics (AKBA) Stock Outpacing Its Medical Peers This Year?
Investing 15:02 Akebia at H.C. Wainwright: Strategic Insights on Kidney Care Products
Seeking Alpha 15:00 Core CPI In Focus With JPMorgan, Goldman, Netflix Set To Report Earnings
Investing 13:59 Akebia Ther stock hits 52-week high at 4.08 USD
Investing 11:35 Akebia Therapeutics expands stock incentive plan
Seeking Alpha 03:36 Akebia Therapeutics (AKBA): Stock At Fair Value Amid Robust Drug Adoption Into 2026
Seeking Alpha 21:26 Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Seeking Alpha 20:23 Akebia Therapeutics: Finally Showing Potential, But Wait For Q2 Earnings First (AKBA)
Investing 12:06 Akebia reports mixed results for anemia drug in global study
Investing 11:04 H.C. Wainwright assumes coverage on Akebia Therapeutics stock with buy rating
Investing 16:06 Akebia Ther stock soars to 52-week high, hits $3.31
Investing 20:52 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 12:28 Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025
Investing 13:48 Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025
Investing 20:02 Akebia Therapeutics at H.C. Wainwright Conference: Vafseo’s Strategic Launch
Investing 13:39 Akebia Therapeutics stock soars to 52-week high of $2.91
Seeking Alpha 13:19 Akebia's Valuation Looks Stretched Despite Auryxia’s Loss Of Exclusivity (NASDAQ:AKBA)
Benzinga 16:01 Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase - Benson Hill (NASDAQ:BHIL), Akebia Therapeutics (NASDAQ:AKBA)
Benzinga 12:18 JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Akebia Therapeutics (NASDAQ:AKBA), Enerflex (NYSE:EFXT)
Benzinga 12:34 Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Akebia Therapeutics (NASDAQ:AKBA), Arlo Technologies (NYSE:ARLO)
Seeking Alpha 14:21 Akebia Therapeutics, Inc. (AKBA) Q4 2024 Earnings Call Transcript
Seeking Alpha 10:43 Akebia: Still Bullish On Vafseo As Auryxia's Revenues Decline (NASDAQ:AKBA)

Tagesspanne

3.47 3.64

Jahresspanne

1.07 4.08

Vorheriger Schlusskurs: 3.59
Eröffnung: 3.63

Bid: 3.51
Ask: 3.81

Tief: 3.47
Hoch: 3.64

Volumen: 3.590 K

Tagesänderung: -3.31%
Monatsänderung: -3.31%

6-Monatsänderung: 63.26%
Jahresänderung: 152.52%

30 Juli, Mittwoch